Total Payments
$2,884
2024 Payments
$433.99
Companies
20
Transactions
182
Medicare Patients
719
Medicare Billing
$86,380
Payment Breakdown by Category
Food & Beverage$2,884 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,884 | 182 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $795.71 | 49 | $0 (2024) |
| GlaxoSmithKline, LLC. | $321.46 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $280.47 | 19 | $0 (2024) |
| Lilly USA, LLC | $279.50 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $200.10 | 13 | $0 (2023) |
| ABBVIE INC. | $180.18 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $171.61 | 12 | $0 (2024) |
| PFIZER INC. | $123.28 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $93.25 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $86.04 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $433.99 | 26 | Novo Nordisk Inc ($175.89) |
| 2023 | $418.07 | 24 | Novo Nordisk Inc ($107.07) |
| 2022 | $502.98 | 30 | Lilly USA, LLC ($126.60) |
| 2021 | $544.43 | 32 | Novo Nordisk Inc ($201.70) |
| 2020 | $273.48 | 19 | AstraZeneca Pharmaceuticals LP ($144.53) |
| 2019 | $534.87 | 40 | Novo Nordisk Inc ($129.96) |
| 2018 | $94.72 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($26.04) |
| 2017 | $81.32 | 4 | Janssen Pharmaceuticals, Inc ($41.73) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Biological | ||||||
| 12/02/2024 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.75 | General |
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: UROLOGY | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $17.91 | General |
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Biological | ||||||
| 08/09/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: HEMATOLOGY | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Obesity | ||||||
| 07/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: Diabetes | ||||||
| 06/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.91 | General |
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Obesity | ||||||
| 03/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Biological | ||||||
| 03/07/2024 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
| 02/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Respiratory | ||||||
| 02/01/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 218 | 560 | $45,365 | $27,154 |
| 2022 | 4 | 111 | 313 | $23,150 | $11,879 |
| 2021 | 4 | 139 | 410 | $31,181 | $16,151 |
| 2020 | 9 | 251 | 610 | $54,042 | $31,197 |
Total Patients
719
Total Services
1,893
Medicare Billing
$86,380
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 65 | 359 | $21,540 | $13,178 | 61.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 51 | $8,160 | $4,836 | 59.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 52 | 71 | $6,745 | $4,225 | 62.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 19 | $4,446 | $2,447 | 55.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 22 | $1,980 | $1,292 | 65.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Facility | 2023 | 16 | 27 | $1,647 | $763.88 | 46.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2023 | 11 | 11 | $847.00 | $412.17 | 48.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 49 | 226 | $13,560 | $6,464 | 47.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 23 | $3,680 | $2,076 | 56.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 34 | $3,060 | $1,752 | 57.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 30 | $2,850 | $1,586 | 55.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 60 | 281 | $16,860 | $8,082 | 47.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 65 | $5,994 | $3,515 | 58.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 24 | 30 | $5,097 | $2,776 | 54.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 31 | 34 | $3,230 | $1,778 | 55.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 53 | 300 | $18,000 | $9,061 | 50.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 126 | $11,340 | $7,068 | 62.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 41 | 43 | $6,880 | $4,356 | 63.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 48 | 53 | $5,035 | $2,902 | 57.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 30 | $3,750 | $2,425 | 64.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $3,276 | $2,189 | 66.8% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 12 | 12 | $2,184 | $1,143 | 52.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 17 | 20 | $1,900 | $1,055 | 55.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 12 | 12 | $1,677 | $996.57 | 59.4% |
About Hannah Ray
Hannah Ray is a Family Medicine healthcare provider based in Flowood, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2015. The National Provider Identifier (NPI) number assigned to this provider is 1023404100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hannah Ray has received a total of $2,884 in payments from pharmaceutical and medical device companies, with $433.99 received in 2024. These payments were reported across 182 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,884).
As a Medicare-enrolled provider, Ray has provided services to 719 Medicare beneficiaries, totaling 1,893 services with total Medicare billing of $86,380. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Flowood, MS
- Active Since 04/15/2015
- Last Updated 07/21/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023404100
Products in Payments
- Ozempic (Drug) $369.58
- TRELEGY ELLIPTA (Drug) $260.33
- FARXIGA (Drug) $206.64
- ENTRESTO (Drug) $165.46
- MOUNJARO (Drug) $160.59
- JARDIANCE (Drug) $141.88
- RYBELSUS (Drug) $137.26
- Tresiba (Drug) $130.17
- VRAYLAR (Drug) $114.83
- Rybelsus (Drug) $85.77
- Yupelri (Drug) $76.47
- TRULICITY (Drug) $66.64
- XARELTO (Drug) $63.89
- Veozah (Drug) $61.14
- AREXVY (Drug) $61.13
- OXBRYTA (Drug) $49.43
- JADA SYSTEM (Device) $39.64
- BYDUREON (Drug) $38.06
- LEQVIO (Drug) $34.64
- ELIQUIS (Drug) $32.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Flowood
Todd Perkins, M.d, M.D
Family Medicine — Payments: $26,375
Family Medicine $26,375
John Madden, M.d, M.D
Family Medicine — Payments: $23,414
Family Medicine $23,414
Rebekah Moulder, M.d, M.D
Family Medicine — Payments: $18,552
Family Medicine $18,552
Landall Hathorn, M.d, M.D
Family Medicine — Payments: $13,988
Family Medicine $13,988
Cynthia Allen, M.d, M.D
Family Medicine — Payments: $13,887
Family Medicine $13,887
Dr. Stephen Hammack, Md, MD
Family Medicine — Payments: $8,622
Family Medicine $8,622